Tozhuo Pharmaceutical Technology

Tozhuo Pharmaceutical Technology is a clinical-stage biopharmaceutical company based in Shanghai, China, specializing in the discovery and development of innovative small molecule therapeutics. The company focuses on high-value targets within the fields of immunology, inflammation, and oncology, with a particular emphasis on selective kinase inhibitors. Its lead programs include highly selective JAK1 and TYK2 inhibitors designed to treat autoimmune conditions such as atopic dermatitis and psoriasis with improved safety profiles. Tozhuo leverages its internal R&D capabilities to advance a pipeline of candidates from early discovery through clinical proof-of-concept.